Post more often, please!!! If our drug continues to be

New Post Public Reply Private Reply Replies (2) Message Board
dejavu SizzlChest #89016
711
Post more often, please!!!

Quote:
If our drug continues to be as effective as we already believe it to be on so many indications, this little molecule changes medicine moving forward. BP is well aware of this.

If anyone thinks for one second that several large BP companies combined are willing to lose 100s of billions posssibly approaching a trillion dollars in revenues over the next 12 years from lost sales due to LL, are not monitoring this board, then that person is foolish.

They arleady pay people to bash the stock around the clock to create confusion, anxiety, and to get us to question our position as longs and keep new investors on the sideline.

They already fund short-sellers coffers to keep the price down to prevent uplisting and media attention. They pay hack attorneys to create a smear campaign to dissuade potential investors. All of this in an attempt to make a buyout more palatable at far less than what this company is worth if it were on a level playing field.

They pull strings with employees at the FDA (jobs, trips, consulting fees), fund the FDA directly, and spend hundreds of millions on lobbyist to keep sales flowing and competition minimized.

They are monitoring this board. They are studying every point made, every little argument we have, every insecurity we list, and they are and will continue to use it against us.

We are not talking about two competing locally owned pizza joints in a little podunk town... We are talking about companies that shape the world in which we live.

I appreciate discussion about our drug and the indications. I do not appreciate telling the enemy our individual investment plans and our perceived weaknesses of the company we own.

All of the 'I would take this price' and 'Nader sucks' stuff ultimately hurts any possibly stock price gains. Nader said 3 digits, he's our captain, end of story.

If anyone is happy at 20$ then sell when we hit 20$... 30$ wait for 30$, 40-50 good on you sell it all and retire... But believe me when Nader said 3 digits that is what he meant! They better come with at least 3 digits or keep spending billions to hold us down.

Also, here's another one for the Nader bashers to think about... If you had the vision for CYDY, risk your families money on it, worked 18+ hours a day jumping through hoops and dealing with a stacked deck, trying to keep investors optimistic in the face of dirty BP tricks, trying to get the best possible financing under the circumstances, having people personally attack you online incessantly, and all the while knowing the board of directors could shit can you at any moment before you saw the fruits of your labor... How much would you pay yourself while you had the chance????

Don't reply, I already know the answer.

We have a gold mine. Keep the location information to yourself, or at least wait until it starts producing gold to tell everyone what you think its worth. And stop with the costant bickering, while it is nice to vent, how much did it end up hitting you in the pocket book???

There are a few things right now that CYDY can/is doing to generate sales and get approvals. I will not share what I believe is happening because I will not give the enemy information to use against us. I hope others are in agreement with this.


GLTA longs!!! Our day is approaching, hang in there

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

US Foods Faces Major Strike Threat Over Driver Contracts

Updated Category News Views 84

Teamsters Prep for Possible Strike Against US Foods You can almost hear the union drums beating as 260 drivers from Teamsters Local 282 in New York gear up for what could be a major confrontation with US Foods. The message is loud and clear: pay us what we're worth, or watch your delivery chain grind to a halt. With unanimous approval to strike, this isn't just a...

Continue Reading
PMET Grows Mineral Assets at Shaakichiuwaanaan

Updated Category News Views 100

Resource Expansion at the Shaakichiuwaanaan Property You ever see a resource report that makes you do a double take? That's the vibe here with PMET's game-changing update on their Shaakichiuwaanaan property in Quebec. They've crunched the numbers at the Helios Caesium Zone and CV4 Pegmatite, and the results? A juicy increase in the grade, scale, and tonnage across three...

Continue Reading
GNSS Simulator Market: $425M by 2031, Key Insight

Updated Category News Views 118

GNSS Simulator Market: Gadgets Meet Growth A market that's been quietly bubbling away on the back burner is about to boil over: The GNSS Simulator Market, pegged at a neat $424.6 million by 2031. Yeah, it might be niche, but those in the know can't get enough of these satellite-signal replicators. Why GNSS Simulators are Crushing It There's a bunch of reasons why GNSS...

Continue Reading
EAF Relief Fund Launches After Learjet Disaster

Updated Category News Views 103

Mobilizing Aid: A Community in Crisis Not every day you wake up to a story that digs into your gut like this one. The folks at the Green Acres Mobile Home Community in Palm Beach County got dealt a raw deal. A Learjet crash shook their world apart on November 1st, leaving nine lives lost on that flight and sending hundreds of residents scrambling from their homes. It's a...

Continue Reading
RSPO RT2026 Tackles Indonesian Fires and Export Shifts

Updated Category News Views 15

Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 151

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
HashKey and AMBR Unite to Push AI Frontiers in Finance

Updated Category News Views 34

Shaping the Future with AI Integration In the whirlwind of innovation, there's always the ones braving the frontier, pushing the very boundaries of what we deem possible. Today, it's HashKey Capital and AMBR joining forces, marching into uncharted financial territories. This partnership is more than just a signature on a piece of paper; it's a declaration—a commitment...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 73

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Silvercorp Updates El Domo Budget Amid Challenges

Updated Category News Views 78

Budget Pains for Silvercorp's El Domo Project Folks, if you thought navigating the stock market was a minefield, try mining these days. Silvercorp Metals Inc. had to bump up its budget for the El Domo project in Ecuador—again. This time by $14.6 million. What's causing this fiscal heartache? Everything from rising diesel prices thanks to Ecuador playing games with...

Continue Reading
BD Appoints Bagnato as Peripheral Intervention Head

Updated Category News Views 13

A New Captain for BD's Peripheral Ship Time to pay attention, folks. Franklin Lakes just sent an interesting ripple through their workforce headlines, announcing Bridget Bagnato taking the reins as Worldwide President of BD's Peripheral Intervention division. Come November 16, this medical tech veteran, who's clocked over 27 years with BD, is set to start steering their...

Continue Reading

Top 5 Most Recently Viewed Articles

SEATOM Selected for NATO's Accelerator Programme Growth

Updated Category News Views 161

SEATOM's Selection for NATO's Accelerator Programme Today, SEATOM announced a significant milestone as it was chosen to participate in the NATO Defence Innovation Accelerator for the North Atlantic (DIANA) 2026 Challenge Programme. This prestigious selection underscores SEATOM's innovative approach to developing nuclear technology tailored for maritime and extreme...

Continue Reading
OpenAI's New Device Development Following $6.5 Billion Acquisition

Updated Category News Views 194

OpenAI Completes a Major Acquisition OpenAI has recently wrapped up a remarkable deal by acquiring Jony Ive's AI hardware startup, io Products, for a staggering $6.5 billion. This acquisition brings the design genius, renowned for his work at a major tech giant, into OpenAI's fold to help create a new generation of smart devices. Key Developments Post-Acquisition The...

Continue Reading
Opportunities for KinderCare Investors Amid Class Action News

Updated Category News Views 151

Opportunities for KinderCare Investors Robbins Geller Rudman & Dowd LLP has announced a significant opportunity for investors of KinderCare Learning Companies, Inc. (NYSE: KLC) who have experienced substantial losses. This is a pivotal moment for shareholders as they can now seek to lead a class action lawsuit against the company. Understanding the Class Action Lawsuit...

Continue Reading
Baltic Horizon Fund Sees Positive NAV Growth in May 2025

Updated Category News Views 128

Growth of Baltic Horizon Fund's NAV in May 2025 The Baltic Horizon Fund reported an increase in its net asset value (NAV) per unit, which rose to EUR 0.6757 at the close of May 2025. This figure represents a slight gain from the NAV of EUR 0.6740 recorded at the end of April 2025. The fund's overall net asset value reached EUR 97.0 million, up from EUR 96.8 million in the...

Continue Reading
Autolus Therapeutics Highlights CARLYSLE Trial Findings at ASH 2025

Updated Category News Views 239

Autolus Therapeutics Showcases CARLYSLE Trial Results Autolus Therapeutics plc (Nasdaq: AUTL), a biopharmaceutical leader in developing innovative T cell therapies, recently showcased promising preliminary data from the CARLYSLE trial, which focuses on severe refractory systemic lupus erythematosus (srSLE). The data were presented during a special session at a leading...

Continue Reading